Answers are grounded in this paper and cite their sources.
Structural analysis reveals the synthesis of a one-dimensional zinc(II) coordination polymer, highlighting the directing role of fluorinated Schiff base ligands in crystal architecture.
This study reports the synthesis and characterization of a dinuclear zinc(II) complex, [Zn2(L1)2(L2)]·DMF·Et3N (C45H54F2N10O5S2Zn2), constructed from a fluoro-substituted thiosemicarbazone Schiff base ligand (2-(3-fluoro-5-hydroxybenzylidene)-N-methylhydrazine-1-carbothioamide, L1) and a rigid bipyridine auxiliary ligand (1,4-di(pyridin-4-yl)-2,5-dimethoxybenzene, L2) under solvothermal conditions. Single-crystal X-ray diffraction analysis reveals that the complex crystallizes in the monoclinic space group C2/c, featuring discrete dinuclear [Zn2] units in which each Zn(II) center adopts a distorted square pyramidal geometry. These dinuclear units are extended into one-dimensional zigzag chains along the crystallographic c-axis via bridging L2 ligands, and further assembled into a two-dimensional supramolecular layer through hydrogen-bonding interactions involving lattice triethylamine and DMF molecules, ultimately forming a three-dimensional network. Both DMF and triethylamine molecules are disordered about a twofold rotation axis. This work highlights the structural directing roles of the fluoro-substituted multidentate Schiff base ligand and the rigid auxiliary ligand in the assembly of zinc(II) coordination polymers.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: